公众号 / 文章心脑血管急症重症综合管理与镇静镇痛

脑组织氧合监测在蛛网膜下腔出血管理中的作用:范围综述

The Role of Brain Tissue Oxygenation Monitoring in the Management of Subarachnoid Hemorrhage: A Scoping Review.
PubMed 文献 · Neurocrit Care · 2023-02-17
一句话结论范围综述提示,对重型蛛网膜下腔出血患者,PbtO2监测可安全评估局部脑组织氧合,最常用15–20 mmHg定义脑组织缺氧并启动治疗。

本范围综述总结了脑组织氧合(PbtO2)监测在蛛网膜下腔出血(SAH)患者中的应用现状。结果显示,PbtO2监测是评估局部脑组织氧合的安全可靠方法,PbtO2代表脑间质中可用于有氧能量产生的氧(即脑血流量与动静脉氧张力差的乘积)。PbtO2探头应置于缺血风险区域(即预计发生脑血管痉挛的血管供血区),最广泛用于定义脑组织缺氧并启动特定治疗的阈值为15–20 mmHg。PbtO2值可帮助识别过度通气、高氧、诱导低温、诱导高血压、红细胞输注、渗透疗法和去骨瓣减压等治疗的需求或效果;低PbtO2值与更差预后相关,治疗反应性PbtO2升高是良好结局的标志。

要点

  • PbtO2监测是评估SAH患者局部脑组织氧合的安全可靠方法,PbtO2代表脑间质中可用于有氧能量产生的氧。
  • PbtO2探头应置于缺血风险区域,即预计发生脑血管痉挛的血管供血区。
  • 最广泛用于定义脑组织缺氧并启动特定治疗的PbtO2阈值为15–20 mmHg。
  • PbtO2值可帮助识别过度通气、高氧、诱导低温、诱导高血压、红细胞输注、渗透疗法和去骨瓣减压等治疗的需求或效果。
  • 低PbtO2值与更差预后相关,治疗反应性PbtO2升高是良好结局的标志。

适用人群与场景

  • 重型蛛网膜下腔出血(poor-grade SAH)患者,尤其是合并迟发性脑缺血者。

诊断标准与关键阈值

  • 最广泛用于定义脑组织缺氧并启动特定治疗的PbtO2阈值为15–20 mmHg。

处置流程与药物剂量

  • PbtO2探头应置于缺血风险区域,即预计发生脑血管痉挛的血管供血区。
  • PbtO2值可帮助识别过度通气、高氧、诱导低温、诱导高血压、红细胞输注、渗透疗法和去骨瓣减压等治疗的需求或效果。

红旗征与不能漏的情况

  • 低PbtO2值与更差预后相关。

研究设计与关键结果

  • PbtO2监测是评估局部脑组织氧合的安全可靠方法。
  • PbtO2代表脑间质中可用于有氧能量产生的氧(即脑血流量与动静脉氧张力差的乘积)。
  • 治疗反应性PbtO2升高是良好结局的标志。

证据类型、等级与局限

  • 证据类型:范围综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对重型SAH患者,尤其是合并迟发性脑缺血者,可考虑使用PbtO2监测评估局部脑组织氧合;探头置于预计发生脑血管痉挛的血管供血区;以15–20 mmHg作为定义脑组织缺氧并启动特定治疗的阈值;PbtO2变化有助于判断过度通气、高氧、诱导低温、诱导高血压、红细胞输注、渗透疗法和去骨瓣减压等治疗的需求或效果。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Monitoring of brain tissue oxygenation (PbtO2) is an important component of multimodal monitoring in traumatic brain injury. Over recent years, use of PbtO2 monitoring has also increased in patients with poor-grade subarachnoid hemorrhage (SAH), particularly in those with delayed cerebral ischemia. The aim of this scoping review was to summarize the current state of the art regarding the use of this invasive neuromonitoring tool in patients with SAH. Our results showed that PbtO2 monitoring is a safe and reliable method to assess regional cerebral tissue oxygenation and that PbtO2 represents the oxygen available in the brain interstitial space for aerobic energy production (i.e., the product of cerebral blood flow and the arterio-venous oxygen tension difference). The PbtO2 probe should be placed in the area at risk of ischemia (i.e., in the vascular territory in which cerebral vasospasm is expected to occur). The most widely used PbtO2 threshold to define brain tissue hypoxia and initiate specific treatment is between 15 and 20 mm Hg. PbtO2 values can help identify the need for or the effects of various therapies, such as hyperventilation, hyperoxia, induced hypothermia, induced hypertension, red blood cell transfusion, osmotic therapy, and decompressive craniectomy. Finally, a low PbtO2 value is associated with a worse prognosis, and an increase of the PbtO2 value in response to treatment is a marker of good outcome.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Gouvea Bogossian E, Battaglini D, Fratino S, et al. The Role of Brain Tissue Oxygenation Monitoring in the Management of Subarachnoid Hemorrhage: A Scoping Review. Neurocrit Care. 2023. PMID: 36802011. doi:10.1007/s12028-023-01680-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。